Pink announced the next four dates on her Summer Carnival Tour have been postponed. The “Raise Your Glass” hitmaker revealed the news via an Instagram post on Saturday morning. “Due to ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

Pink is an American singer and songwriter who has a net worth of $250 million. P!nk emerged in the late 1990s as a member of the R&B group Choice before launching her solo career with her 2000 ...

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...

NEW YORK - The feds are issuing a new warning about a drug cocktail called pink cocaine. The feds say it's a popular party drug they're finding on New York City streets. It was also named in a ...

DETROIT - Before she performed Cirque du Soleil-type stunts at her first of two concerts in Detroit this week, P!NK was out and about visiting one of Michigan’s most popular tourist attractions ...

Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction ...

Longboard is a clinical-stag Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash.

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.